These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23474562)

  • 1. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
    Ramfidis VS; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
    Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
    J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampullary cancer: an overview.
    Ahn DH; Bekaii-Saab T
    Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Ampullary Adenocarcinoma].
    Shin DW
    Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
    Dhakhwa R; Kafle N
    JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ampullary Mixed Adenoneuroendocrine Carcinoma: Surprise Histology, Familiar Management.
    Mahansaria SS; Agrawal N; Arora A; Bihari C; Appukuttan M; Chattopadhyay TK
    Int J Surg Pathol; 2017 Oct; 25(7):585-591. PubMed ID: 28552015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
    J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
    Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
    Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after resection of ampullary carcinoma: a national population-based study.
    O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
    Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periampullary tumours: report of two cases.
    Kassa E
    East Afr Med J; 1996 May; 73(5):333-5. PubMed ID: 8756040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
    Roder JD; Siewert JR
    Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pancreaticoduodenectomy for locally recurrent or metastatic carcinoma to the periampullary region.
    Nakeeb A; Lillemoe KD; Cameron JL
    J Am Coll Surg; 1995 Feb; 180(2):188-92. PubMed ID: 7850053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
    Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal recurrence of ampullary carcinoma following curative pancreatoduodenectomy.
    Yoshida T; Matsumoto T; Sasaki A; Aramaki M; Kawano K; Kitano S
    Hepatogastroenterology; 1999; 46(30):3274-5. PubMed ID: 10626200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.